Hui Pan

Hui Pan

Auto-generated profile, based on publicly available information

Hui Pan

Bioinformatics and Biostatistics Core, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2019 in JCI Insight
Verified
Journal Article
Open access
PDF file
SOSoravis Osataphan
Soravis Osataphan
CMChiara Macchi
Chiara Macchi
GSGarima Singhal
Garima Singhal
JCJeremy Chimene-Weiss
Jeremy Chimene-Weiss
VSVicencia Sales
Vicencia Sales
MPMary-Elizabeth Patti
Mary-Elizabeth Patti
Pharmacologic inhibition of the renal sodium/glucose cotransporter-2 induces glycosuria and reduces glycemia. Given that SGLT2 inhibitors (SGLT2i) reduce mortality and cardiovascular risk in type 2 diabetes, improved understanding of molecular mechanisms mediating these metabolic effects is required. Treatment of obese but nondiabetic mice with the SGLT2i canagliflozin (CANA) reduces adiposity, improves glucose tolerance despite reduced plasma insulin, increases plasma ketones, and improves plasma lipid profiles. Utilizing an integrated transcriptomic-metabolomics approach, we demonstrate that CANA modulates key nutrient-sensing pathways, with activation of 5′ AMP-activated protein kinase (AMPK) and inhibition of mechanistic target of rapamycin (mTOR), independent of insulin or glucagon sensitivity or signaling. Moreover, CANA induces transcriptional reprogramming to activate catabolic pathways, increase fatty acid oxidation, reduce hepatic steatosis and diacylglycerol content, and increase hepatic and plasma levels of FGF21. Given that these phenotypes mirror the effects of FGF21 to promote lipid oxidation, ketogenesis, and reduction in adiposity, we hypothesized that FGF21 is required for CANA action. Using FGF21-null mice, we demonstrate that FGF21 is not required for SGLT2i-mediated induction of lipid oxidation and ketogenesis but is required for reduction in fat mass and activation of lipolysis. Taken together, these data demonstrate that SGLT2 inhibition triggers a fasting-like transcriptional and metabolic paradigm but requires FGF21 for reduction in adiposity.

20 April 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HNHirofumi Nagao
Hirofumi Nagao
WCWeikang Cai
Weikang Cai
NANicolai Wewer Albrechtsen
Nicolai Wewer Albrechtsen
MSMartin Steger
Martin Steger
TBThiago M. Batista
Thiago M. Batista
CKC. Ronald Kahn
C. Ronald Kahn
Significance: Insulin and IGF-1 receptors share many downstream signaling pathways but have unique biological effects. Here, using global phosphoproteomics, we demonstrate that there are important differences in phosphorylation-mediated signaling between IR and IGF1R in both the basal and ligand-stimulated states involving multiple pathways of cellular regulation. Thus, mTORC1 and PIP3/AKT signaling, which are important in metabolism, are preferentially regulated by IR, while Rho GTPases, mitosis, and cell cycle proteins, which are involved in control of cellular growth, are preferentially regulated by IGF1R. These differences can be mapped to effects of both the extracellular and intracellular domains of these receptors. Thus, despite their high homology, IR and IGF1R preferentially regulate distinct networks of phosphorylation, contributing to the unique effects of these hormones.

1 November 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
NHNida Haider
Nida Haider
JLJasmin Lebastchi
Jasmin Lebastchi
AJAshok Kumar Jayavelu
Ashok Kumar Jayavelu
TBThiago M. Batista
Thiago M. Batista
HPHui Pan
Hui Pan
CKC. Ronald Kahn
C. Ronald Kahn
Insulin resistance is present in one-quarter of the general population, predisposing these people to a wide range of diseases. Our aim was to identify cell-intrinsic determinants of insulin resistance in this population using induced pluripotent stem cell–derived (iPSC–derived) myoblasts (iMyos). We found that these cells exhibited a large network of altered protein phosphorylation in vitro. Integrating these data with data from type 2 diabetic iMyos revealed critical sites of conserved altered phosphorylation in IRS-1, AKT, mTOR, and TBC1D1 in addition to changes in protein phosphorylation involved in Rho/Rac signaling, chromatin organization, and RNA processing. There were also striking differences in the phosphoproteome in cells from men versus women. These sex-specific and insulin-resistance defects were linked to functional differences in downstream actions. Thus, there are cell-autonomous signaling alterations associated with insulin resistance within the general population and important differences between men and women, many of which also occur in diabetes, that contribute to differences in physiology and disease.

29 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JDJonathan M. Dreyfuss
Jonathan M. Dreyfuss
YYYixing Yuchi
Yixing Yuchi
XDXuehong Dong
Xuehong Dong
VEVissarion Efthymiou
Vissarion Efthymiou
HPHui Pan
Hui Pan
MPMary Elizabeth Patti
Mary Elizabeth Patti
To improve the power of mediation in high-throughput studies, here we introduce High-throughput mediation analysis (Hitman), which accounts for direction of mediation and applies empirical Bayesian linear modeling. We apply Hitman in a retrospective, exploratory analysis of the SLIMM-T2D clinical trial in which participants with type 2 diabetes were randomized to Roux-en-Y gastric bypass (RYGB) or nonsurgical diabetes/weight management, and fasting plasma proteome and metabolome were assayed up to 3 years. RYGB caused greater improvement in HbA1c, which was mediated by growth hormone receptor (GHR). GHR’s mediation is more significant than clinical mediators, including BMI. GHR decreases at 3 months postoperatively alongside increased insulin-like growth factor binding proteins IGFBP1/BP2; plasma GH increased at 1 year. Experimental validation indicates (1) hepatic GHR expression decreases in post-bariatric rats; (2) GHR knockdown in primary hepatocytes decreases gluconeogenic gene expression and glucose production. Thus, RYGB may induce resistance to diabetogenic effects of GH signaling.Trial Registration: Clinicaltrials.gov NCT01073020.

9 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
NCNan Chiang
Nan Chiang
XSXavier de la Rosa Siles
Xavier de la Rosa Siles
SLStephania Libreros
Stephania Libreros
HPHui Pan
Hui Pan
JDJonathan M. Dreyfuss
Jonathan M. Dreyfuss
CSCharles Serhan
Charles Serhan
The recently elucidated proresolving conjugates in tissue regeneration (CTR) maresin-CTR (MCTR), protectin-CTR (PCTR), and resolvin-CTR (RCTR), termed cysteinyl-specialized proresolving mediators (cys-SPMs) each promotes regeneration, controls infection, and accelerates resolution of inflammation. Here, we sought evidence for cys-SPM activation of primordial pathways in planaria (Dugesia japonica) regeneration that might link resolution of inflammation and regeneration. On surgical resection, planaria regeneration was enhanced with MCTR3, PCTR3, or RCTR3 (10 nM), each used for RNA sequencing. The three cys-SPMs shared up-regulation of 175 known transcripts with fold-change > 1.25 and combined false discovery rate (FDR) < 0.002, and 199 canonical pathways (FDR < 0.25), including NF-κB pathways and an ortholog of human TRAF3 (TNFR-associated factor 3). Three separate pathway analyses converged on TRAF3 up-regulation by cys-SPMs. With human macrophages, three cys-SPMs each dose-dependently increased TRAF3 expression in a cAMP-PKA–dependent manner. TRAF3 overexpression in macrophages enhanced Interleukin-10 (IL-10) and phagocytosis of Escherichia coli. IL-10 also increased phagocytosis in a dose-dependent manner. Silencing of mouse TRAF3 in vivo significantly reduced IL-10 and macrophage phagocytosis. TRAF3 silencing in vivo also relieved cys-SPMs’ actions in limiting polymorphonuclear neutrophil in E. coli exudates. These results identify cys-SPM–regulated pathways in planaria regeneration, uncovering a role for TRAF3/IL-10 in regulating mammalian phagocyte functions in resolution. Cys-SPM activation of TRAF3 signaling is a molecular component of both regeneration and resolution of infectious inflammation. Significance Resolution of inflammation, infection, and injury are essential for host defense and homeostasis. Cysteinyl-specialized proresolving mediators (cys-SPMs) are potent chemical signals that accelerate resolution of inflammation, control infection, and display proregenerative properties. We sought evidence for cys-SPM–activated primordial pathways that might link resolution of inflammation and regeneration using planaria because of their robust regenerative ability. RNA sequencing was carried out with surgically resected planaria exposed to cys-SPMs, and we identified genes and pathways regulated by cys-SPMs during the regeneration, including TRAF3. In mammalian systems, TRAF3 contributes to cys-SPM–stimulated phagocyte functions and resolution of infection.

4 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
HNHirofumi Nagao
Hirofumi Nagao
AJAshok Kumar Jayavelu
Ashok Kumar Jayavelu
WCWeikang Cai
Weikang Cai
HPHui Pan
Hui Pan
JDJonathan M. Dreyfuss
Jonathan M. Dreyfuss
CKC. Ronald Kahn
C. Ronald Kahn
Insulin acts through the insulin receptor (IR) tyrosine kinase to exert its classical metabolic and mitogenic actions. Here, using receptors with either short or long deletion of the β-subunit or mutation of the kinase active site (K1030R), we have uncovered a second, previously unrecognized IR signaling pathway that is intracellular domain-dependent, but ligand and tyrosine kinase-independent (LYK-I). These LYK-I actions of the IR are linked to changes in phosphorylation of a network of proteins involved in the regulation of extracellular matrix organization, cell cycle, ATM signaling and cellular senescence; and result in upregulation of expression of multiple extracellular matrix-related genes and proteins, down-regulation of immune/interferon-related genes and proteins, and increased sensitivity to apoptosis. Thus, in addition to classical ligand and tyrosine kinase-dependent (LYK-D) signaling, the IR regulates a second, ligand and tyrosine kinase-independent (LYK-I) pathway, which regulates the cellular machinery involved in senescence, matrix interaction and response to extrinsic challenges.